Recombinant multi-species PRDX1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRDX1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides. The encoded protein may play an antioxidant protective role in cells, and may contribute to the antiviral activity of CD8(+) T-cells. This protein may have a proliferative effect and play a role in cancer development or progression. Four transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jan 2011]
The Alternative Names of target: Hbp23,MSP23,NKEF-A,NKEFA,Natural killer cell-enhancing factor A (NKEF-A),NkefA,OSF-3,OSF3,PAG,PAGA,PAGB,PRDX1,PRX1,PRXI,Paga,Peroxiredoxin-1,Prdx1,PrdxI,Proliferation-associated gene protein (PAG),PrxI,TDPX2,TDX2,TPxA,Tdpx2,Thioredoxin peroxidase 2,Thioredoxin-dependent peroxide reductase 2,Thioredoxin-dependent peroxiredoxin 1,prx1
Go
to PRDX1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP9194-Ag-1/ GM-Tg-hg-IP9194-Ag-2 | Human PRDX1 protein | Human |
| GM-Tg-rg-IP9194-Ag-1/ GM-Tg-rg-IP9194-Ag-2 | Rat PRDX1 protein | Rat |
| GM-Tg-mg-IP9194-Ag-1/ GM-Tg-mg-IP9194-Ag-2 | Mouse PRDX1 protein | Mouse |
| GM-Tg-cynog-IP9194-Ag-1/ GM-Tg-cynog-IP9194-Ag-2 | Cynomolgus/Rhesus macaque PRDX1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP9194-Ag-1/ GM-Tg-felg-IP9194-Ag-2 | Feline PRDX1 protein | Feline |
| GM-Tg-cang-IP9194-Ag-1/ GM-Tg-cang-IP9194-Ag-2 | Canine PRDX1 protein | Canine |
| GM-Tg-bovg-IP9194-Ag-1/ GM-Tg-bovg-IP9194-Ag-2 | Bovine PRDX1 protein | Bovine |
| GM-Tg-equg-IP9194-Ag-1/ GM-Tg-equg-IP9194-Ag-2 | Equine PRDX1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP9194-Ag-1/ GM-Tg-hg-IP9194-Ag-2;
GM-Tg-rg-IP9194-Ag-1/ GM-Tg-rg-IP9194-Ag-2;
GM-Tg-mg-IP9194-Ag-1/ GM-Tg-mg-IP9194-Ag-2; GM-Tg-cynog-IP9194-Ag-1/ GM-Tg-cynog-IP9194-Ag-2; GM-Tg-felg-IP9194-Ag-1/ GM-Tg-felg-IP9194-Ag-2; GM-Tg-cang-IP9194-Ag-1/ GM-Tg-cang-IP9194-Ag-2; GM-Tg-bovg-IP9194-Ag-1/ GM-Tg-bovg-IP9194-Ag-2; GM-Tg-equg-IP9194-Ag-1/ GM-Tg-equg-IP9194-Ag-2 |
| Products Name | PRDX1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PRDX1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRDX1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.